Assembly Biosciences (ASMB) Research & Development (2010 - 2026)

Assembly Biosciences' Research & Development history runs 17 years deep, the most recent figure standing at $14.9 million for Q1 2026.

• On a quarterly basis, Research & Development changed 0.33% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $64.9 million, a 10.11% increase from a year earlier, with the FY2025 full-year figure at $64.8 million, up 15.88% from the prior year.
• Research & Development slipped to $14.9 million in Q1 2026 per ASMB's latest filing, from $17.2 million in the prior quarter.
• Across five years, Research & Development topped out at $18.1 million in Q3 2022 and bottomed at $10.8 million in Q3 2023.
• The 5-year median for Research & Development is $14.9 million (2026), against an average of $15.0 million.
• Across the five-year window, Research & Development sank 40.3% in 2023 and increased 29.83% in 2024, its largest moves.
• Year by year, Research & Development stood at $16.9 million in 2022, then slumped by 34.69% to $11.0 million in 2023, then climbed by 29.75% to $14.3 million in 2024, then climbed by 20.8% to $17.2 million in 2025, then fell by 13.62% to $14.9 million in 2026.
• Per Business Quant, the three latest ASMB Research & Development figures stand at $14.9 million (Q1 2026), $17.2 million (Q4 2025), and $16.6 million (Q3 2025).